These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25491350)

  • 1. Variations in Guideline-Concordant Breast Cancer Adjuvant Therapy in Rural Georgia.
    Guy GP; Lipscomb J; Gillespie TW; Goodman M; Richardson LC; Ward KC
    Health Serv Res; 2015 Aug; 50(4):1088-108. PubMed ID: 25491350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
    Wu XC; Lund MJ; Kimmick GG; Richardson LC; Sabatino SA; Chen VW; Fleming ST; Morris CR; Huang B; Trentham-Dietz A; Lipscomb J
    J Clin Oncol; 2012 Jan; 30(2):142-50. PubMed ID: 22147735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Nonconcordance With NCCN Guidelines on Resource Utilization, Cost, and Mortality in De Novo Metastatic Breast Cancer.
    Rocque GB; Williams CP; Jackson BE; Ingram SA; Halilova KI; Pisu M; Kenzik KM; Azuero A; Forero A; Bhatia S
    J Natl Compr Canc Netw; 2018 Sep; 16(9):1084-1091. PubMed ID: 30181420
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of Diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast Cancer Treatment for Breast Cancer.
    Gold HT; Shao H; Oratz R; Yu O; Hammer M; Richardson S; Boudreau D
    Am J Clin Oncol; 2020 Feb; 43(2):101-106. PubMed ID: 31850918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
    Fang P; He W; Gomez DR; Hoffman KE; Smith BD; Giordano SH; Jagsi R; Smith GL
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):748-757. PubMed ID: 28366580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline-Concordant Treatment Among Elderly Women With HER2-Positive Metastatic Breast Cancer in the United States.
    Vyas AM; Aroke H; Kogut S
    J Natl Compr Canc Netw; 2020 Apr; 18(4):405-413. PubMed ID: 32259787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receipt of Guideline-Concordant Care Among Older Women With Stage I-III Breast Cancer: A Population-Based Study.
    LeMasters T; Madhavan SS; Sambamoorthi U; Hazard-Jenkins HW; Kelly KM; Long D
    J Natl Compr Canc Netw; 2018 Jun; 16(6):703-710. PubMed ID: 29891521
    [No Abstract]   [Full Text] [Related]  

  • 9. Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.
    Griggs JJ; Culakova E; Sorbero ME; Poniewierski MS; Wolff DA; Crawford J; Dale DC; Lyman GH
    J Clin Oncol; 2007 Jun; 25(18):2522-7. PubMed ID: 17577029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of guideline-recommended adjuvant therapies and survival outcomes for people with colorectal cancer at tertiary referral hospitals in South Australia.
    Adelson P; Fusco K; Karapetis C; Wattchow D; Joshi R; Price T; Sharplin G; Roder D
    J Eval Clin Pract; 2018 Feb; 24(1):135-144. PubMed ID: 28474459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasis.
    Rocque GB; Williams CP; Kenzik KM; Jackson BE; Azuero A; Halilova KI; Ingram SA; Pisu M; Forero A; Bhatia S
    Cancer; 2018 Nov; 124(21):4231-4240. PubMed ID: 30317547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of locoregional treatment for nonmetastatic breast cancer by patient and health system factors.
    Anderson RT; Morris CR; Kimmick G; Trentham-Dietz A; Camacho F; Wu XC; Sabatino SA; Fleming ST; Lipscomb J
    Cancer; 2015 Mar; 121(5):790-9. PubMed ID: 25369150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US.
    Lipscomb J; Gillespie TW; Goodman M; Richardson LC; Pollack LA; Ryerson AB; Ward KC
    Breast Cancer Res Treat; 2012 May; 133(1):285-96. PubMed ID: 22278190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer.
    Sabatino SA; Thompson TD; Wu XC; Fleming ST; Kimmick GG; Trentham-Dietz A; Cress R; Anderson RT
    Breast Cancer Res Treat; 2014 Jul; 146(1):199-209. PubMed ID: 24899083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level.
    Verschoor AM; Kuijer A; Verloop J; Van Gils CH; Sonke GS; Jager A; van Dalen T; Elias SG
    Breast Cancer Res Treat; 2016 Sep; 159(2):357-65. PubMed ID: 27514397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer treatment guidelines in older women.
    Giordano SH; Hortobagyi GN; Kau SW; Theriault RL; Bondy ML
    J Clin Oncol; 2005 Feb; 23(4):783-91. PubMed ID: 15681522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of care with regard to surgical choice and application of adjuvant radiation therapy for preinvasive and early stage breast cancer in rural Appalachia.
    Freeman AB; Huang B; Dragun AE
    Am J Clin Oncol; 2012 Aug; 35(4):358-63. PubMed ID: 21422902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Adjuvant Hormone Therapy Use in Medicaid Managed Care-Insured Women, New York State, 2012-2014.
    Wagner VL; Jing W; Boscoe FP; Schymura MJ; Roohan PJ; Gesten FC
    Prev Chronic Dis; 2016 Sep; 13():E120. PubMed ID: 27584876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer.
    Cronin DP; Harlan LC; Potosky AL; Clegg LX; Stevens JL; Mooney MM
    Am J Gastroenterol; 2006 Oct; 101(10):2308-18. PubMed ID: 17032196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of patient, physician, and hospital characteristics on the receipt of guideline-concordant care for inflammatory breast cancer.
    Denu RA; Hampton JM; Currey A; Anderson RT; Cress RD; Fleming ST; Lipscomb J; Sabatino SA; Wu XC; Wilson JF; Trentham-Dietz A
    Cancer Epidemiol; 2016 Feb; 40():7-14. PubMed ID: 26605428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.